Logo image
Mechanically interlocked functionalization of monoclonal antibodies
Journal article   Open access   Peer reviewed

Mechanically interlocked functionalization of monoclonal antibodies

Krzysztof P. Bzymek, James W. Puckett, Cindy Zer, Jun Xie, Yuelong Ma, Jeremy D. King, Leah H. Goodstein, Kendra N. Avery, David Colcher, Gagandeep Singh, …
Nature Communications, Vol.9(1)
2018

Abstract

Animals Antibodies, Monoclonal Azides Binding Sites Cetuximab Click Chemistry Drug Carriers Female Immunoglobulin Fab Fragments Mice Mice, Inbred NOD Mice, SCID Protein Binding Receptor, ErbB-2 Surface Plasmon Resonance Trastuzumab Mus azide immunoglobulin F(ab) fragment monoclonal antibody cetuximab drug carrier epidermal growth factor receptor 2 Erbb2 protein, mouse immunoglobulin F(ab) fragment monoclonal antibody protein binding trastuzumab antibody antigen complexity fluorescence radionuclide rodent toxin tumor animal experiment animal model animal tissue antigen specificity Article click chemistry female hydrogen bond mouse nonhuman tumor model animal binding site chemistry click chemistry immunology nonobese diabetic mouse procedures SCID mouse surface plasmon resonance
Because monoclonal antibodies (mAbs) have exceptional specificity and favorable pharmacology, substantial efforts have been made to functionalize them, either with potent cytotoxins, biologics, radionuclides, or fluorescent groups for therapeutic benefit and/or use as theranostic agents. To exploit our recently discovered meditope-Fab interaction as an alternative means to efficiently functionalize mAbs, we used insights from the structure to enhance the affinity and lifetime of the interaction by four orders of magnitude. To further extend the lifetime of the complex, we created a mechanical bond by incorporating an azide on the meditope, threading the azide through the Fab, and using click chemistry to add a steric group. The mechanically interlocked, meditope-Fab complex retains antigen specificity and is capable of imaging tumors in mice. These studies indicate it is possible to "snap" functionality onto mAbs, opening the possibility of rapidly creating unique combinations of mAbs with an array of cytotoxins, biologics, and imaging agents. © 2018 The Author(s).
url
https://doi.org/10.1038/s41467-018-03976-5View
Published (Version of record) Open

Metrics

4 Record Views

Details

Logo image